In a study of 172 post-operative CRC patients, the risk of recurrence was significantly higher for those with positive ctDNA (methylated BCAT1/IKZF1) within 12 months of surgery compared to those who were negative (HR 3.8, 95% CI 1.5–9.5). The gene discussed is IKZF1; the disease is colorectal carcinoma.